EU drug regulator finds possible link between AstraZeneca vaccine and rare blood clots

AstraZeneca has said previously its studies have found no higher risk of blood clots in those vaccinated than in the general population

The European Medicines Agency (EMA) said on Wednesday it had found a possible link between AstraZeneca's coronavirus vaccine and reports of very rare cases of blood clots in people who had received the shot. Safety concerns have prompted more than a dozen countries in recent weeks to suspend use of the vaccine, which has been given to tens of millions of people in Europe, after reports linking it to a brain blood clotting disorder in a few dozen recipients. EU health ministers have been told that the EMA's decision on the safety of the vaccine will have immediate implications for vaccination plans and to require a coordinated response, a letter seen by Reuters showed.